Abstract
Objectives
The objective of this study was to identify clinical and imaging features that distinguish rheumatoid lung nodules from malignancy.
Methods
We conducted a retrospective review of 73 rheumatoid patients with histologically-proven rheumatoid and malignant lung nodules encountered at Mayo Clinic, Rochester, MN (2001–2016). Medical records and imaging were reviewed including a retrospective blinded review of CT and PET/CT studies.
Results
The study cohort had a mean age of 67 ± 11 years (range 45–86) including 44 (60%) women, 82% with a smoking history, 38% with subcutaneous rheumatoid nodules, and 78% with rheumatoid factor seropositivity. Subjects with rheumatoid lung nodules compared to malignancy were younger (59 ± 12 vs 71 ± 9 years, p < 0.001), more likely to manifest subcutaneous rheumatoid nodules (73% vs 20%, p < 0.001) and rheumatoid factor seropositivity (93% vs 68%, p = 0.034) but a history of smoking was common in both groups (p = 0.36). CT features more commonly associated with rheumatoid lung nodules compared to malignancy included multiplicity, smooth border, cavitation, satellite nodules, pleural contact, and a subpleural rind of soft tissue. Optimal sensitivity (77%) and specificity (92%) (AUC 0.85, CI 0.75–0.94) for rheumatoid lung nodule were obtained with ≥ 3 CT findings (≥ 4 nodules, peripheral location, cavitation, satellite nodules, smooth border, and subpleural rind). Key 18FDG-PET/CT features included low-level metabolism (SUVmax 2.7 ± 2 vs 7.2 ± 4.8, p = 0.007) and lack of 18F-fluorodeoxyglucose (FDG)-avid draining lymph nodes.
Conclusion
Rheumatoid lung nodules have distinct CT and PET/CT features compared to malignancy. Patients with rheumatoid lung nodules are younger and more likely to manifest subcutaneous rheumatoid nodules and seropositivity.
Key Points
• Rheumatoid lung nodules have distinct clinical and imaging features compared to lung malignancy.
• CT features of rheumatoid lung nodules include multiplicity, cavitation, satellite nodules, smooth border, peripheral location, and subpleural rind.
• Key PET/CT features include low-level metabolism and lack of FDG-avid draining lymph nodes.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-018-5755-x/MediaObjects/330_2018_5755_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-018-5755-x/MediaObjects/330_2018_5755_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-018-5755-x/MediaObjects/330_2018_5755_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-018-5755-x/MediaObjects/330_2018_5755_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-018-5755-x/MediaObjects/330_2018_5755_Fig5_HTML.png)
Similar content being viewed by others
Abbreviations
- CCP:
-
Cyclic citrullinated peptide
- DLCO:
-
Diffusing capacity for carbon monoxide
- FEV1 :
-
Forced expiratory volume in 1 s
- FDG:
-
18F-fluorodeoxyglucose
- FVC:
-
Forced vital capacity
- GGO:
-
Ground glass opacity
- HRCT:
-
High-resolution computed tomography
- IL-1:
-
Interleukin-1
- PET:
-
Positron emission tomography
- PFT:
-
Pulmonary function test
- RA:
-
Rheumatoid arthritis
- TLC:
-
Total lung capacity
References
Golden SE, Wiener RS, Sullivan D, Ganzini L, Slatore CG (2015) Primary care providers and a system problem: a qualitative study of clinicians caring for patients with incidental pulmonary nodules. Chest 148:1422–1429
MacMahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology https://doi.org/10.1148/radiol.2017161659:161659
Jolles H, Moseley PL, Peterson MW (1989) Nodular pulmonary opacities in patients with rheumatoid arthritis. A diagnostic dilemma. Chest 96:1022–1025
Schwarz K (2011) Interstitial lung disease. Shelton, Conn. : People's Medical Pub. House
Kitamura A, Matsuno T, Narita M, Shimokata K, Yamashita Y, Mori N (2004) Rheumatoid arthritis with diffuse pulmonary rheumatoid nodules. Pathol Int 54:798–802
(2001) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-2001. A 53-year-old woman with arthritis and pulmonary nodules. N Engl J Med 344:997–1004
Highton J, Hung N, Hessian P, Wilsher M (2007) Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane. Rheumatology (Oxford) 46:811–814
Hull S, Mathews JA (1982) Pulmonary necrobiotic nodules as a presenting feature of rheumatoid arthritis. Ann Rheum Dis 41:21–24
Gupta P, Ponzo F, Kramer EL (2005) Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules. Clin Rheumatol 24:402–405
Rozin A, Yigla M, Guralnik L et al (2006) Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 25:384–388
Glace B, Gottenberg JE, Mariette X et al (2012) Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Ann Rheum Dis 71:1429–1431
Gómez Herrero H, Arraiza Sarasa M, Rubio Marco I, García de Eulate Martín-Moro I (2012) Pulmonary rheumatoid nodules: presentation, methods, diagnosis and progression in reference to 5 cases. Reumatol Clin 8:212–215
Toussirot E, Berthelot JM, Pertuiset E et al (2009) Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. J Rheumatol 36:2421–2427
Cortet B, Flipo RM, Rémy-Jardin M et al (1995) Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 54:815–819
Mori S, Cho I, Koga Y, Sugimoto M (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513–1521
Rémy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B (1994) Lung changes in rheumatoid arthritis: CT findings. Radiology 193:375–382
Yousem SA, Colby TV, Carrington CB (1985) Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131:770–777
Walker WC, Wright V (1968) Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 47:501–520
Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588
Mukhopadhyay S, Wilcox BE, Myers JL et al (2013) Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest 144:813–824
Mukhopadhyay S, Gal AA (2010) Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med 134:667–690
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722
MacMahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 284:228–243
Noonan CD, Taylor FB Jr, Engleman EP (1963) Nodular rheumatoid disease of the lung with cavitation. Arthritis Rheum 6:232–240
Walters MN, Ojeda VJ (1986) Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients. Med J Aust 144:648–651
Mikuls TR, Hughes LB, Westfall AO et al (2008) Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 67:1529–1534
Nyhäll-Wåhlin BM, Jacobsson LT, Petersson IF, Turesson C, BARFOT study group (2006) Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis. Ann Rheum Dis 65:601–606
Mattey DL, Dawes PT, Fisher J et al (2002) Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction. J Rheumatol 29:2313–2318
Jones JS (1978) An account of pleural effusions, pulmonary nodules and cavities attributable to rheumatoid disease. Br J Dis Chest 72:39–56
Macfarlane JD, Dieppe PA, Rigden BG, Clark TJ (1978) Pulmonary and pleural lesions in rheumatoid disease. Br J Dis Chest 72:288–300
Patterson CD, Harville WE, Pierce JA (1965) Rheumatoid lung disease. Ann Intern Med 62:685–697
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Dr. Jay H. Ryu.
Conflict of interest
Dr. Johnson has received research funding from Pfizer which is not relevant to this work. None of the additional co-authors have relevant disclosures.
Statistics and biometry
Mr. Paul A. Decker kindly provided statistical advice for this manuscript.
Informed consent
The study was approved by the Mayo Clinic Institutional Review Board (IRB16-006571). According to Mayo Clinic institutional policy, patient information may be used for research purposes only with prior patient consent.
Ethical approval
Institutional Review Board approval was obtained by the Mayo Clinic Institutional Review Board (IRB16-006571).
Study subjects or cohorts overlap
None of the study subjects or cohorts have been previously reported except for abstract presentation at the American Thoracic Society International Conference 2017.
Methodology
• Retrospective
• Case-control study
• Performed at one institution
Rights and permissions
About this article
Cite this article
Koslow, M., Young, J.R., Yi, E.S. et al. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol 29, 1684–1692 (2019). https://doi.org/10.1007/s00330-018-5755-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5755-x